Analyst Ratings for Processa Pharmaceuticals (PCSA)

PCSA Rating Summary

PCSA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PCSA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $1.00 (-64.7%) * Over Last 12-Mos
Rating Score: 8 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/25/2024 H.C. Wainwright
» Updated 9/2/2025
Raghuram Selvaraju New Coverage Buy
(N/A)
1.00
(2.00)
1.62
(2.83)
74.69% Details
11/17/2023 Maxim Group Naz Rahman Downgrade Hold
(Buy)
N/A
(N/A)
0.42
(2.83)
573.81% Details